Zoetis Inc. reports $9.5B FY 2025 revenue and 83.5% gross margins with a low 18x earnings valuation and 12 blockbusters. See why ZTS stock is a buy.

The annual results for Zoetis Inc. (NYSE:ZTS) were released last week, making it a good time to revisit its performance. It ...

Zoetis (ZTS) stock falls even after the company beat Street forecasts with its Q4 2025 results as its outlook indicates ...

Animal health company Zoetis (NYSE:ZTS) announced better-than-expected revenue in Q4 CY2025, with sales up 3% year on year to ...

Animal health company Zoetis (NYSE:ZTS) will be announcing earnings results this Thursday morning. Here’s what to expect.

Zoetis Inc. ZTS will release earnings for its fourth quarter before the opening bell on Thursday, Feb. 12. Analysts expect the Parsippany, New Jersey-based company to report quarterly earnings at $1.4 ...

Investing.com -- Zoetis (NYSE:ZTS) stock climbed 3% after the animal health company reported fourth-quarter earnings that beat analyst expectations and provided an optimistic outlook for fiscal year ...

By Sahil Pandey Feb 12 (Reuters) - Zoetis on Thursday forecast 2026 adjusted profit and revenue above Wall Street estimates, but shares dropped 5% after executives cautioned that its companion-animal ...

Zoetis returned more than $3.2 billion through share repurchases and $800 million in dividends in 2025, signaling confidence in its long-term outlook. The company also completed a convertible bond ...

INHERIT® genetic predictions identify genetics for productivity and health during critical phase in beef herd rebuilding.

INHERIT lets cattle producers select replacement females and evaluate sires based on genetic predictions for BRD health and ...

Animal healthcare company Zoetis next reports quarterly earnings pre-market on Feb. 12. Whether shares surge or sink post-earnings may hinge on the company's guidance updates. For long-term investors, ...